[COPD treatment by drugs].
作者信息
Nafti S
机构信息
Clinique des Maladies Respiratoires, Hôpital Mustapha, CHU Alger Centre - 16000 Alger, Algérie.
出版信息
Rev Mal Respir. 2006 Sep;23(4 Pt 2):10S58-10S60.
PMID:17127967
Abstract
摘要
相似文献
1
[COPD treatment by drugs].
Rev Mal Respir. 2006 Sep;23(4 Pt 2):10S58-10S60.
2
[Do we need inhalative steroids in chronic COPD patients?].
Med Klin (Munich). 2002 Dec 15;97 Suppl 2:15-9.
3
Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Pharmacotherapy. 2009 Sep;29(9):1039-53. doi: 10.1592/phco.29.9.1039.
4
[When beta-mimetic and anticholinergic agents fail in COPD. More air with theophylline].
MMW Fortschr Med. 2004 Apr 29;146(18):57.
5
Chronic obstructive pulmonary disease.
Clin Evid. 2006 Jun(15):2077-100.
6
[The new COPD guidelines reviewed. Smoking cessation--and what else?].
MMW Fortschr Med. 2003 Feb 20;145(8):6-8.
7
[How risky are beta-2 mimetics?].
MMW Fortschr Med. 2006 Aug 17;148(33-34):10.
8
Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
Clin Ther. 2007 Oct;29(10):2121-33. doi: 10.1016/j.clinthera.2007.10.006.
9
[New drug therapy of chronic obstructive pulmonary disease].
Nihon Rinsho. 2003 Dec;61(12):2175-80.
10
[Clinical aspects of anticholinergic agents].
Rev Mal Respir. 1998 Sep;15 Suppl 2:S51-4.
Zotero 插件